In light of recent news that Angelina Jolie underwent a double mastectomy to reduce her risk of breast cancer, many women are wondering whether they should follow suit. They may be asking themselves, “Am I at risk? Is surgery right for me? Should my family members be concerned about their health?” These are all valid questions.
Compass Oncology's Genetic Risk Evaluation and Testing (GREAT) Program is a leader in personalized cancer-risk reduction. By examining the personal and family history, our experts can best determine whether patients should be tested for mutations that increase their risk for certain hereditary cancers.
Dr. Langer is a medical oncologist, Director of Compass Oncology’s Genetic Risk Evaluation and Testing (GREAT) program, and Medical Director of Cancer Genetics for US Oncology. In addition to over 15 years experience in genetic research at some of the nation’s leading institutions, she has advanced subspecialty expertise in breast cancer, lung cancer and lymphomas.
Fast Facts about Genetic Risks for Cancer: